when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

BioSpace·33m ago·1 min read

BMS R&D head to depart amid restructure

Nov 12, 2026·read at BioSpace ↗

Bristol Myers Squibb is combining all research and development efforts under one leader as pressure rises to replenish its pipeline.

source

Reporting by BioSpace.

read at BioSpace ↗

sharex / twitter linkedin

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

1h agoCan we finally get ahead of drug shortages?BioSpace
8h ago2026 Q3 Job Market Report: Job opportunities, layoffs show YOY improvementBioSpace
8h agoBiopharma layoffs rise YOY in October but sharply trend down for 2026BioSpace
9h ago10 companies hiring in New JerseyBioSpace
21h agoFDA warns Chinese providers of compounding APIs over record-request refusalsBioSpace